ClinicalTrials.gg
CompletedNCT05404828TUCSONUpdated Sep 19, 2024

TUCSON Study: Tackling Underlying Causes of Sleep Related Nocturia Nocturia

An observational study in Nocturia, Insomnia and OSA, sponsored by University Hospital, Ghent. Completed at 1 site in Belgium. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-09-19.

Sponsored by University Hospital, Ghent · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
65
Ages
18 Years and older
Sex
All
01

Study summary

The TUCSON study is a cross-sectional observational monocentric study. In order to provide a clinical helpful assessment for urologists for possible missed causes of nocturia, the aim is to investigate the voiding and sleep pattern through questionnaires and sleep and voiding diaries of patients consulting the urology department, sleep clinic and pneumology department. An assessment of the prevalence of missed underlying causes will be made and a subset of patients will be asked to deliver urine samples from every night time and first morning void to further investigate possible differences in urine content between the groups. First of all, with this research the aim to offer an idea about the order of magnitude for missed underlying causes of nocturia. Secondly, to discover a specific sleep and voiding pattern for the different entities of nocturia and thirdly, to offer a useful screening tool for underlying pathology in clinical practice.

Read the detailed description

Study rationale and unmet medical need:

In current urological practice, patients complaining from nocturia are not systematically screened for underlying pathology that could cause their nocturnal voiding complaints. Even though guidelines recommend screening for other factors besides the urological ones, it remains difficult to implement these strategies in daily practice during consultation. Clear cut questionnaires to screen for OSAS or underlying sleep disorders remain cumbersome and it is yet to be investigated if there is a difference in voiding and sleep pattern between the different causal entities of nocturia.

In order to provide a clinical helpful assessment for urologists for possible missed causes of nocturia, we aim to investigate the voiding and sleep pattern through questionnaires and sleep and voiding diaries in patients consulting the urology department, sleep clinic and pneumology department. An assessment of the prevalence of missed underlying causes will be made and a subset of patients will be asked to deliver urine samples from every night time and first morning void to further investigate possible differences in urine content between the groups.

First of all, with this research the aim is to offer an idea about the order of magnitude for missed underlying causes of nocturia. Secondly, to offer a useful screening tool for underlying pathology in clinical practice and thirdly, to discover a specific sleep and voiding pattern for the different entities of nocturia.

Study objectives:

  • To gather cross-sectional information about the underlying cause of nocturia in patients consulting a urologist, sleep specialist or pneumologist.
  • The collected data will be saved in a protected and pseudonymised database.
  • Sleep, urinary symptoms, sleep apnea and quality of life will be assessed through appropriate questionnaires that patients will need to fill in before treatment.
  • The tango questionnaire will be compared to the results from the above mentioned questionnaires in order to assess the value of the Tango questionnaire as a complete screening tool for underlying causes of nocturia, even in first line practice.
  • A subset of patients will be asked to take urine samples from every night time and first void in the morning during one night, with a fasting blood collection the following morning. For patients undergoing a PSG, the urine collection and blood draw will be collected during that night.
  • Patients will be asked to keep a 7 day nighttime only voiding diary, a 7 day sleep diary and a 3 day FVC. Patients undergoing a PSG will be asked to fill in the last day of their sleep and voiding diary during that night.
  • Validation of the FUSP (First Uninterrupted Sleep Period) concept, by comparing data from the PSG to the sleep and voiding diaries.
  • Information on comorbidities, medical history and medication use will be derived from the electronic patient files.
02

Conditions studied

  • Nocturia
  • Insomnia
  • OSA

Keywords

  • Nocturia
  • Insomnia
  • Sleep Apnea, Obstructive
  • Polysomnography
03

In context

Nocturia

126 studies on the registry are indexed under Nocturia; 24 are open to participants now.

This study's enrollment of 65 is below the median of 275 across 26 observational studies indexed under Nocturia.

Browse Nocturia studies →

Lead sponsor

University Hospital, Ghent is the lead sponsor of 685 studies on the registry; 158 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 4 (80%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients will be included by their treating physician from either the urology department for complaints of nocturia, the pneumology department for OSAS or the center for integrative medicine for insomnia complaints.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • All adult patients >18 years
  • Nocturia 2x/night or more

Exclusion criteria

Exclusion Criteria:

  • current UTI
  • SNM during the last year
  • Botox during the last year
  • working night shifts during the past 2 weeks
  • Pregnant or breastfeeding women
  • PTNS/SANS during the past 2 weeks.
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
65 participants (actual)
Patient registry
No
Biospecimen retention
Samples without dna

Groups and cohorts

  • OSAS

    All adult patients consulting the pneumology department for possible OSAS with \>1x/night nocturia

    Other: Polysomnography · Other: Questionnaires · Other: Blood and urine sample

  • Insomnia

    All adult patients consulting the center for integrative medicine for insomnia with \>1x/night nocturia

    Other: Polysomnography · Other: Questionnaires · Other: Blood and urine sample

  • Urological

    All adult patients consulting the urology department with \>1x/night nocturia

    Other: Polysomnography · Other: Questionnaires · Other: Blood and urine sample

Interventions

  • OtherPolysomnography

    Polysomnography: WASO, FUSP, TST, TIB, SEF, Global Wake Index, Sleep Latency, AHI

  • OtherQuestionnaires

    STOP-BANG, ISI, ESS, PSQI, MTCQ, ICIQ-F/MLUTS, IRLS, TANGO, SF36

  • OtherBlood and urine sample

    Na, K, Creat, Osm, Urea

06

What researchers measure

Primary outcomes

  1. Voiding pattern

    Differences in voiding frequency volume charts

    Time frame: 1 week

Secondary outcomes

  1. Sleep pattern

    Differences in sleeping parameters derived from PSG and sleep diaries. The combined measurements will provide information on sleep quality, total sleep time, the number of awakenings etc

    Time frame: 1 week

  2. Solute excretion

    Differences in urinary composition: Na, Urea, Osm, Creat

    Time frame: 1 night

07

Study locations

1 site
  • Ghent University Hospital
    Ghent, East-Fanders 9000, Belgium
08

References and documents

Publications

  • Verbakel I, Boukheir G, Bliwise D, Vogelaers D, Mariman A, Everaert K. Deciphering Sleepless Nights: Nocturia Analyzed Through a CART-Based Predictive Model in Patients With Insomnia. Retrospective Data From the TUCSON Study. Neurourol Urodyn. 2026 Jun 8. doi: 10.1002/nau.70318. Online ahead of print. PubMed 42257317 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 19, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05404828
Collaborators
University Ghent
Responsible party
Sponsor
First posted
Jun 3, 2022
Start date
Feb 28, 2022
Primary completion
Jan 30, 2024
Completion
Jan 30, 2024
Last update
Sep 19, 2024

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion